Applications and validation analyses shown in the manuscript
The two network files used in the case scenario.
To validate the disease-drug pairs prioritized by Drug2ways, we used clinical trial information (i.e., drugs that have been tested on a given indication) from ClinicalTrials.gov mapped to each of the networks.